Trial Profile
A retrospective study investigating correlations between microvascular invasion and peritumoral decreased uptake area (PDUA) and elucidating the predictability of PDUA for tumor recurrence after resection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2017
Price :
$35
*
At a glance
- Drugs Gadoxetate disodium (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- 21 Sep 2017 New trial record
- 01 Aug 2017 Results published in the Medicine